These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 227432)
41. Lipoprotein substrates of lipoprotein lipase and hepatic triacylglycerol lipase from human post-heparin plasma. Musliner TA; Herbert PN; Kingston MJ Biochim Biophys Acta; 1979 Nov; 575(2):277-88. PubMed ID: 228741 [No Abstract] [Full Text] [Related]
42. Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Herrera E; Lasunción MA; Gomez-Coronado D; Aranda P; López-Luna P; Maier I Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1575-83. PubMed ID: 3287929 [TBL] [Abstract][Full Text] [Related]
43. Lipoprotein lipase with a defect in lipid interface recognition in a case with type I hyperlipidaemia. Kobayashi J; Shirai K; Saito Y; Yoshida S Eur J Clin Invest; 1989 Oct; 19(5):424-32. PubMed ID: 2511018 [TBL] [Abstract][Full Text] [Related]
44. Hyperlipoproteinemia: metabolic basis and rationale for therapy. Grundy SM Am J Cardiol; 1984 Aug; 54(5):20C-26C. PubMed ID: 6089539 [TBL] [Abstract][Full Text] [Related]
45. Accelerated turnover of very low density lipoprotein triglycerides in chronic alcohol users. A possible mechanism for the up-regulation of high density lipoprotein by ethanol. Sane T; Nikkilä EA; Taskinen MR; Välimäki M; Ylikahri R Atherosclerosis; 1984 Nov; 53(2):185-93. PubMed ID: 6517974 [TBL] [Abstract][Full Text] [Related]
46. Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins. Haberbosch W; Poli A; Baggio G; Fellin R; Gnasso A; Augustin J Biochim Biophys Acta; 1984 Mar; 793(1):49-60. PubMed ID: 6704413 [TBL] [Abstract][Full Text] [Related]
47. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)]. Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG Lab Delo; 1983; (6):29-38. PubMed ID: 6193318 [No Abstract] [Full Text] [Related]
48. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins. Gotto AM Am J Cardiol; 1990 Sep; 66(6):20A-23A. PubMed ID: 2203246 [TBL] [Abstract][Full Text] [Related]
49. Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action. Sacks FM; Dzau VJ Am J Med; 1986 Feb; 80(2A):71-81. PubMed ID: 3080883 [TBL] [Abstract][Full Text] [Related]
50. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204 [TBL] [Abstract][Full Text] [Related]
51. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism? Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025 [TBL] [Abstract][Full Text] [Related]
52. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL. Murdoch SJ; Breckenridge WC Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314 [TBL] [Abstract][Full Text] [Related]
53. An approach to the management of hyperlipoproteinemia. Hoeg JM; Gregg RE; Brewer HB JAMA; 1986 Jan 24-31; 255(4):512-21. PubMed ID: 3510334 [TBL] [Abstract][Full Text] [Related]
54. Hyperlipoproteinemia in renal insufficiency. Heuck CC; Ritz E Nephron; 1980; 25(1):1-7. PubMed ID: 6986036 [TBL] [Abstract][Full Text] [Related]
55. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy. Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185 [TBL] [Abstract][Full Text] [Related]
56. Primary hypertriglyceridemia in childhood. Deckelbaum RJ; Dupont C; LeTarte J; Pencharz P Am J Dis Child; 1983 Apr; 137(4):396-8. PubMed ID: 6829521 [TBL] [Abstract][Full Text] [Related]
57. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975 [TBL] [Abstract][Full Text] [Related]
58. Primary type I hyperlipoproteinaemia--a metabolic and family study. Potter JM; Macdonald WB Aust N Z J Med; 1979 Dec; 9(6):688-93. PubMed ID: 294927 [TBL] [Abstract][Full Text] [Related]
59. Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia. Brunzell JD; Bierman EL Med Clin North Am; 1982 Mar; 66(2):455-68. PubMed ID: 7040847 [TBL] [Abstract][Full Text] [Related]
60. Familial lipoprotein lipase-activity deficiency: study of total body fatness and subcutaneous fat tissue distribution. Brun LD; Gagné C; Julien P; Tremblay A; Moorjani S; Bouchard C; Lupien PJ Metabolism; 1989 Oct; 38(10):1005-9. PubMed ID: 2796749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]